JDD Highlights
The September issue of the Journal of Drugs in Dermatology is available now. This month, we focus on aesthetic treatments, with special features on Public Health, Anti-aging, Aesthetic, and Medical Dermatology.
Read the September JDD Now
Aesthetics, Public Health, Anti-Aging, and Medical Dermatology
The September issue of the Journal of Drugs in Dermatology is available now. This month, we focus on aesthetic treatments, with special features on Public Health, Anti-aging, Aesthetic, and Medical Dermatology.
Article Highlights
- Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products in Melasma compares a HQ-free, retinol-free cosmetic topical brightener and HQ 4% in patients with skin types III-VI.
- Complication of Soft Tissue Fillers: Prevention and Management Review highlights the various adverse effects noted with the use of fillers and discusses prevention and management.
- There is a need for further evaluation of HA fillers for aesthetic use in Asia, where treatment goals may differ from western countries in Safety and Effectiveness of Hyaluronic Acid Fillers With Lidocaine for Full-Face Treatment in Asian Patients.
- Telangiectasia improvement with minimal downtime was assessed in Efficacy and Safety of Intense Pulsed Light With a KTP/PDL-like Filter for the Treatment of Facial Telangiectasias.
- Authors evaluate a cellulite treatment in Human Pharmacokinetics and Safety of Subcutaneous Collagenase Clostridium Histolyticum in Women.
Editor's Picks
-
Reconstruction of Cutaneous Defects of the Ear Using the Post-Auricular Reservoir: A Systematic Review illustrate the versatility of the post-auricular and mastoid skin reservoir for auricular repairs.
-
The Impact of Pharmacy Benefit Managers on Drug Pricing discusses what is behind the price of a medication that we see today.
You May Also Like
Evaluating Dietary Strategies as Adjunctive Interventions in Inflammatory Skin Disease As patients increasingly seek non-pharmacologic interventions to support their psoriasis treatment, interest in dietary modifications has surged. However, clinical guidance…
From JDD's Vault: The State of Sunscreens in the US: Caveat Emptor With the FDA’s groundbreaking June 2026 approval of a new sunscreen ingredient, bemotrizinol (also called BEMT or Tinosorb…
Beyond the Skin: Navigating Psoriasis Treatment and Patient Burden Management of psoriasis can often involve trialing several medications, extensive patient counseling, and working with insurance companies to get the optimal…
